Mixed Martial Arts Group Limited (MMA) is a publicly traded Consumer Cyclical sector company. As of May 21, 2026, MMA trades at $0.52 with a market cap of $14.20M and a P/E ratio of 0.00. MMA moved -2.37% today. Year to date, MMA is -57.93%; over the trailing twelve months it is -34.51%. Its 52-week range spans $0.35 to $4.11. Rallies surfaces MMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MMA.INC Secures 50/50 Revenue Share Partnership for Peptide Recovery Products: MMA.INC entered an exclusive strategic marketing partnership with Precision Peptide to market U.S.-manufactured, third-party tested peptide recovery products across its global combat sports ecosystem. Under the deal, MMA.INC will receive 50% net revenue share in year one and 25% thereafter from MMA-sourced sales.
| Metric | Value |
|---|---|
| Price | $0.52 |
| Market Cap | $14.20M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.33% |
| 52-Week High | $4.11 |
| 52-Week Low | $0.35 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
MMA analyst coverage data. Average price target: $0.00.